The expanding role of the receptor tyrosine kinase MET as a therapeutic target in non-small cell lung cancer
Summary: Aberrant regulation of MET receptor tyrosine kinase activity is a frequent event in non-small cell lung cancer (NSCLC), even though the frequency of oncogenic driver mutations of MET is low. Our discovery of oncogenic MET exon 14 skipping mutations, the characterization of the first prototy...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2025-03-01
|
| Серии: | Cell Reports Medicine |
| Предметы: | |
| Online-ссылка: | http://www.sciencedirect.com/science/article/pii/S2666379125000564 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|